The FDA approves a new treatment for Prostate cancer which was developed by a private company. The drug (injection) lowers testosterone level which result in reducing growth of the tumors in the prostate. This cancer is the 2nd in number of cancer deaths in the United States, about 190,000 men were diagnosed with it and 29,000 died from prostate cancer in 2004, so new treatments and research are always in need.

Read the full story (Yahoo)

You must be logged in to post a comment.